AriBio Herzion

Technology. Validation. Pathway.

A 40 Hz vibroacoustic brain health device

Why Canada, Why Partner

AriBio brings the core asset.
Canada explores the validation and regulatory pathway.

This is not a simple distribution opportunity. It is a chance to shape a Canada-focused brain health device pathway.

What AriBio Brings

Device. Certification. Clinical Progress.

GBC Prime

Herzion Device

Wearable 40Hz vibroacoustic platform

GBC Prime

Certified Safety Base

CE/EMC · CB · RoHS · KC-related materials

GBC Prime

Clinical Progress

Reported exploratory clinical progress in Korea

GBC Prime
Daejin
TradeKorea

What We Hope to Explore in Canada

Validation. Regulatory Review. Market

Clinical validation. Regulatory strategy. Canada market entry.

Validation Model

Class III Pathway

Built for Canadian Brain Health Collaboration

HERZION is being explored for Canadian clinical validation, regulatory pathway assessment, and brain health collaboration.

40Hz Stimulation

Vibroacoustic brain health technology

Brain Health Validation

Evidence planning for Canada

Canada Market Pathway

Regulatory classification review and potential partner-led entry

Explore the Canada Pathway

From Korean clinical progress
to Canadian validation pathway.